CymitQuimica logo
HER

HER

HER inhibitors are compounds that block the activity of Human Epidermal Growth Factor Receptors, particularly HER2, which is overexpressed in certain breast cancers and other malignancies. Inhibition of HER signaling pathways is a key strategy in targeted cancer therapies. At CymitQuimica, we offer HER inhibitors to support your research in oncology, targeted therapies, and cell signaling.

Found 10 products for "HER".

  • Panomifene HCl
    Targetmol
    + Info

    Panomifene HCl

    CAS:
    Panomifene HCl is a selective anti-estrogenic compound with antitumor activity for the treatment of breast cancer.
    Formula:C25H25ClF3NO2
    Purity:99.53%
    Color and Shape:Solid
    Molecular weight:463.92

    Ref: TM-T33876L

  • HER2/neu (654-662) GP2 acetate
    Targetmol
    + Info

    HER2/neu (654-662) GP2 acetate

    GP2 acetate, from HER2 (654-662), triggers HLA-A2-restricted T cells to attack epithelial cancers.
    Formula:C44H81N9O13
    Purity:98%
    Color and Shape:Solid
    Molecular weight:944.17

    Ref: TM-TP1583L

  • Coprelotamab
    Targetmol
    + Info

    Coprelotamab

    CAS:
    Coprelotamab is a humanized mAb targeting HER2 that inhibits tumor growth by blocking receptor dimerization and mediating ADCC, used for HER2-positive cancer research.
    Purity:95%
    Color and Shape:Transparent Liquid

    Ref: TM-T80596

  • CymitQuimica logo
    Targetmol
    + Info

    Trastuzumab-anns

    CAS:
    Trastuzumab-anns is a biosimilar of Herceptin and a monoclonal antibody targeting HER2 that is used for HER2-positive breast cancer and gastric cancer.
    Purity:95%
    Color and Shape:Liquid
    Molecular weight:~150 kDa

    Ref: TM-T76971

  • PF-04929113 Mesylate
    Targetmol
    + Info

    PF-04929113 Mesylate

    CAS:
    PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37
    Formula:C26H34F3N5O7S
    Purity:99% - 99.46%
    Color and Shape:Solid
    Molecular weight:617.638

    Ref: TM-T4342

  • PF04929113
    Targetmol
    + Info

    PF04929113

    CAS:
    PF04929113 (SNX-5422), a synthetic small molecule Hsp90 inhibitor, offers potent efficacy orally for various cancers.
    Formula:C25H30F3N5O4
    Purity:99.04%
    Color and Shape:Solid
    Molecular weight:521.532

    Ref: TM-T6341

  • BMS 599626 2HCl
    Targetmol
    + Info

    BMS 599626 2HCl

    CAS:
    BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100
    Formula:C27H29FN8O3Cl2
    Purity:99.94%
    Color and Shape:Soild
    Molecular weight:603.48

    Ref: TM-T5398

  • Anbenitamab
    Targetmol
    + Info

    Anbenitamab

    CAS:
    Anbenitamab (KN-026) is a HER2 biparatopic bispecific antibody that exerts potent anti-tumor efficacy by inhibiting HER2 signaling and mediating ADCC.
    Color and Shape:Liquid

    Ref: TM-T76905

  • CymitQuimica logo
    Targetmol
    + Info

    Cinrebafusp alfa

    CAS:
    Cinrebafusp alfa is a CD137/HER2 bispecific antibody mediating T cell co-stimulation, with potential in HER2-positive solid tumor research.
    Purity:95%
    Color and Shape:Liquid

    Ref: TM-T80590

  • HER2-IN-12
    Targetmol
    + Info

    HER2-IN-12

    CAS:
    HER2-IN-12 is a selective HER2 inhibitor; blocks autophosphorylation; inhibits signaling; breast cancer research.
    Formula:C17H18BrN5O2S
    Color and Shape:Solid
    Molecular weight:436.33

    Ref: TM-T62487